(0.91%) 5 064.20 points
(0.85%) 38 226 points
(1.51%) 15 841 points
(0.16%) $79.08
(-0.64%) $2.02
(-0.02%) $2 309.20
(0.08%) $26.85
(0.35%) $966.00
(-0.06%) $0.932
(-0.11%) $10.98
(-0.15%) $0.797
(1.50%) $92.49
Live Chart Being Loaded With Signals
PerkinElmer, Inc. provides products, services, and solutions to the diagnostics, life sciences, and applied services markets worldwide. It operates through two segments, Discovery & Analytical Solutions and Diagnostics...
Stats | |
---|---|
今日成交量 | 1.63M |
平均成交量 | 808 389 |
市值 | 14.46B |
EPS | $0 ( 2024-02-12 ) |
下一个收益日期 | ( $0 ) 2024-05-09 |
Last Dividend | $0.0700 ( 2023-07-20 ) |
Next Dividend | $0 ( N/A ) |
P/E | 41.45 |
ATR14 | $3.13 (2.60%) |
Date | Person | Action | Amount | type |
---|---|---|---|---|
2023-12-15 | Gonzales Anita | Buy | 248 | Common Stock |
2023-12-15 | Gonzales Anita | Buy | 706 | NQ Stock Option (right to buy) |
2023-11-27 | Michas Alexis P | Sell | 250 | Common Stock |
2023-11-28 | Michas Alexis P | Sell | 230 | Common Stock |
2023-06-15 | Gonzales Anita | Buy | 329 | Common Stock |
INSIDER POWER |
---|
28.95 |
Last 100 transactions |
Buy: 270 652 | Sell: 165 378 |
音量 相关性
PerkinElmer Inc 相关性
10 最正相关 |
---|
10 最负相关 |
---|
你知道吗?
相关性是描述两个变量之间关系的统计指标。它的取值范围为-1到1,其中-1表示完全负相关(一个变量增加,另一个变量减少),1表示完全正相关(一个变量增加,另一个变量也增加),0表示没有相关性(变量之间没有关系)。
相关性可用于分析任何两个变量之间的关系,而不仅仅是股票。它通常用于金融、经济学、心理学等领域。
PerkinElmer Inc 相关性 - 货币/商品
PerkinElmer Inc 财务报表
Annual | 2022 |
营收: | $3.31B |
毛利润: | $1.99B (60.08 %) |
EPS: | $4.59 |
FY | 2022 |
营收: | $3.31B |
毛利润: | $1.99B (60.08 %) |
EPS: | $4.59 |
FY | 2022 |
营收: | $3.31B |
毛利润: | $1.99B (60.08 %) |
EPS: | $4.59 |
FY | 2021 |
营收: | $5.07B |
毛利润: | $2.85B (56.27 %) |
EPS: | $7.39 |
Financial Reports:
No articles found.
PerkinElmer Inc Dividends
(Q3/22) | (Q4/22) | (Q1/23) | (Q2/23) | (Q3/23) | (Q4/23) | (Q1/24) | (Q2/24) | (Q3/24) | (Q4/24) |
$0.0700 (N/A) |
$0.0700 (N/A) |
$0.0700 (N/A) |
$0.0700 (N/A) |
$0.0700 (N/A) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
Very Unsafe
High risk of being cut
Unsafe
Heightened risk of being cut
Borderline
Moderate risk of being cut
Safe
Unlikely to be cut
Very Safe
Very unlikely to be cut
First Dividend | $0.0225 | 1983-04-18 |
Last Dividend | $0.0700 | 2023-07-20 |
Next Dividend | $0 | N/A |
Payout Date | 2023-08-11 | |
Next Payout Date | N/A | |
# dividends | 164 | -- |
Total Paid Out | $10.25 | -- |
Avg. Dividend % Per Year | 0.11% | -- |
Score | 4.72 | -- |
Div. Sustainability Score | 9.50 | |
Div.Growth Potential Score | 4.99 | |
Div. Directional Score | 7.24 | -- |
Year | Amount | Yield |
---|---|---|
1983 | $0.0675 | 1.00% |
1984 | $0.100 | 1.24% |
1985 | $0.120 | 1.52% |
1986 | $0.130 | 1.36% |
1987 | $0.140 | 1.98% |
1988 | $0.150 | 1.78% |
1989 | $0.170 | 2.38% |
1990 | $0.190 | 2.20% |
1991 | $0.210 | 2.66% |
1992 | $0.245 | 2.03% |
1993 | $0.325 | 3.27% |
1994 | $0.280 | 3.15% |
1995 | $0.350 | 4.79% |
1996 | $0.280 | 2.35% |
1997 | $0.280 | 2.82% |
1998 | $0.280 | 2.68% |
1999 | $0.280 | 1.94% |
2000 | $0.280 | 1.35% |
2001 | $0.280 | 0.58% |
2002 | $0.280 | 0.80% |
2003 | $0.280 | 3.17% |
2004 | $0.280 | 1.60% |
2005 | $0.280 | 1.27% |
2006 | $0.280 | 1.17% |
2007 | $0.280 | 1.28% |
2008 | $0.280 | 1.10% |
2009 | $0.280 | 1.98% |
2010 | $0.280 | 1.36% |
2011 | $0.280 | 1.08% |
2012 | $0.280 | 1.36% |
2013 | $0.280 | 0.87% |
2014 | $0.280 | 0.68% |
2015 | $0.280 | 0.64% |
2016 | $0.280 | 0.53% |
2017 | $0.280 | 0.53% |
2018 | $0.280 | 0.38% |
2019 | $0.280 | 0.36% |
2020 | $0.280 | 0.28% |
2021 | $0.280 | 0.19% |
2022 | $0.280 | 0.15% |
2023 | $0.210 | 0.15% |
2024 | $0 | 0.00% |
The company's strong Dividend Sustainability Score (DSS) indicates its robust capacity to uphold current dividend levels. Unfortunately, its low Dividend Growth Potential Score (DGPS) suggests limited prospects for dividend growth. In summary, the company provides a promising overall dividend outlook, balancing both sustainability and growth potential.
Symbol | Title | Last dividend | Frequency | Years Dividend | Yearly Dividend | Score |
---|---|---|---|---|---|---|
LOMA | Dividend Knight | 2023-06-30 | Quarterly | 2 | 5.23% | 8.53 |
JQC | Dividend Royal | 2023-11-14 | Monthly | 22 | 6.56% | 8.50 |
PHK | Dividend Royal | 2023-11-10 | Monthly | 22 | 6.88% | 8.50 |
ZTR | Dividend Royal | 2024-02-09 | Monthly | 37 | 8.35% | 8.50 |
PCF | Dividend King | 2023-12-18 | Monthly | 38 | 7.05% | 8.50 |
PVL | Dividend King | 2023-11-15 | Monthly | 14 | 9.37% | 8.50 |
KIO | Dividend Royal | 2023-12-14 | Monthly | 12 | 7.05% | 8.50 |
NCV | Dividend Royal | 2024-02-09 | Monthly | 22 | 7.68% | 8.50 |
SBR | Dividend Royal | 2023-11-14 | Monthly | 38 | 7.74% | 8.50 |
SCM | Dividend King | 2023-12-15 | Monthly | 13 | 7.08% | 8.50 |
Ratio | Actual Value | Weight | Normalized Value | Score | Range |
---|---|---|---|---|---|
netProfitMarginTTM | 0.0790 | 1.500 | 8.42 | 10.00 | [0 - 0.5] |
returnOnAssetsTTM | 0.0118 | 1.200 | 9.61 | 10.00 | [0 - 0.3] |
returnOnEquityTTM | 0.0216 | 1.500 | -0.871 | -1.306 | [0.1 - 1] |
payoutRatioTTM | 0.0527 | -1.000 | 9.47 | -9.47 | [0 - 1] |
currentRatioTTM | 2.58 | 0.800 | 2.11 | 1.689 | [1 - 3] |
quickRatioTTM | 1.974 | 0.800 | 3.10 | 2.48 | [0.8 - 2.5] |
cashRatioTTM | 0.974 | 1.500 | 5.70 | 8.55 | [0.2 - 2] |
debtRatioTTM | 0.317 | -1.500 | 4.72 | -7.08 | [0 - 0.6] |
interestCoverageTTM | 5.12 | 1.000 | 9.21 | 9.21 | [3 - 30] |
operatingCashFlowPerShareTTM | 1.616 | 2.00 | 9.46 | 10.00 | [0 - 30] |
freeCashFlowPerShareTTM | 1.240 | 2.00 | 9.38 | 10.00 | [0 - 20] |
debtEquityRatioTTM | 0.573 | -1.500 | 7.71 | -10.00 | [0 - 2.5] |
grossProfitMarginTTM | 0.589 | 1.000 | 3.51 | 3.51 | [0.2 - 0.8] |
operatingProfitMarginTTM | 0.125 | 1.000 | 9.51 | 9.51 | [0.1 - 0.6] |
cashFlowToDebtRatioTTM | 0.0450 | 1.000 | -0.861 | -0.861 | [0.2 - 2] |
assetTurnoverTTM | 0.149 | 0.800 | -2.34 | -1.870 | [0.5 - 2] |
Total Score | 9.50 |
Ratio | Actual Value | Weight | Normalized Value | Score | Range |
---|---|---|---|---|---|
peRatioTTM | 86.07 | 1.000 | 1.407 | 0 | [1 - 100] |
returnOnEquityTTM | 0.0216 | 2.50 | -0.560 | -1.306 | [0.1 - 1.5] |
freeCashFlowPerShareTTM | 1.240 | 2.00 | 9.59 | 10.00 | [0 - 30] |
dividendYielPercentageTTM | 0.0607 | 1.500 | 8.48 | 0 | [0 - 0.4] |
operatingCashFlowPerShareTTM | 1.616 | 2.00 | 9.46 | 10.00 | [0 - 30] |
payoutRatioTTM | 0.0527 | 1.500 | 9.47 | -9.47 | [0 - 1] |
pegRatioTTM | 3.48 | 1.500 | 10.00 | 0 | [0.5 - 2] |
operatingCashFlowSalesRatioTTM | 0.0953 | 1.000 | -0.116 | 0 | [0.1 - 0.5] |
Total Score | 4.99 |
PerkinElmer Inc
PerkinElmer, Inc. provides products, services, and solutions to the diagnostics, life sciences, and applied services markets worldwide. It operates through two segments, Discovery & Analytical Solutions and Diagnostics. The Discovery & Analytical Solutions segment offers a suite of solutions, including reagents, informatics, and detection and imaging technologies that enable scientists to enhance research breakthroughs in the life sciences research market, as well as contract research and laboratory services. It also provides analytical technologies, solutions, and services for the environmental, food, and industrial markets that enable its customers to understand the characterize the health of various aspects, including air, water, and soil. In addition, this segment offers solutions to farmers and food producers; and analytical instrumentation for the industrial market, which includes the chemical, semiconductor and electronics, energy, lubricant, petrochemical, and polymer industries. The Diagnostics segment provides instruments, reagents, assay platforms, and software products for the early detection of genetic disorders, such as pregnancy and early childhood, as well as infectious disease testing in the diagnostics market. Its products are used for testing and screening genetic abnormalities, disorders, and diseases, including down syndrome, hypothyroidism, muscular dystrophy, infertility, and various metabolic conditions. This segment also develops technologies that enable and support genomic workflows using protein coupled receptor and next-generation DNA sequencing for applications in oncology, immunodiagnostics, and drug discovery. It serves pharmaceutical and biotechnology companies, laboratories, academic and research institutions, public health authorities, private healthcare organizations, doctors, and government agencies. PerkinElmer, Inc. was founded in 1937 and is headquartered in Waltham, Massachusetts.
关于 实时信号
此页面上呈现的实时信号有助于确定何时购买或出售NA. 信号具有高达1分钟的延迟;与所有市场信号一样,存在误差或错误的可能性。
实时交易信号不是绝对的,getagraph.com 对基于这些信号采取的任何行动概不负责,如《使用条款》中所述。这些信号是基于广泛的技术分析指标。